There has been a marked shift in the pharmaceutical companies that began the most clinical trials last year.

Novartis has surged to the top of the table while last year’s biggest clinical trial starter, Merck has sunk to the bottom.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.
  • View similar charts
View this report and others on GlobalData GlobalData